Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 25% ± 5% | |
squamous epithelial cell | 4 studies | 28% ± 18% | |
endothelial cell | 3 studies | 24% ± 8% | |
GABAergic neuron | 3 studies | 34% ± 6% | |
glutamatergic neuron | 3 studies | 41% ± 4% | |
astrocyte | 3 studies | 24% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 28% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2172.20 | 1445 / 1445 | 100% | 13.81 | 183 / 183 |
lung | 100% | 2086.20 | 577 / 578 | 100% | 9.57 | 1152 / 1155 |
prostate | 100% | 2960.64 | 245 / 245 | 99% | 18.71 | 499 / 502 |
kidney | 100% | 2356.11 | 89 / 89 | 99% | 9.06 | 894 / 901 |
bladder | 100% | 1807.14 | 21 / 21 | 99% | 8.66 | 500 / 504 |
breast | 100% | 2177.54 | 459 / 459 | 99% | 13.23 | 1108 / 1118 |
pancreas | 100% | 2089.30 | 328 / 328 | 99% | 7.67 | 176 / 178 |
thymus | 100% | 2416.28 | 653 / 653 | 99% | 8.35 | 598 / 605 |
brain | 99% | 1348.52 | 2622 / 2642 | 99% | 6.95 | 701 / 705 |
intestine | 100% | 1838.66 | 966 / 966 | 98% | 8.60 | 518 / 527 |
stomach | 100% | 1698.04 | 359 / 359 | 98% | 10.23 | 281 / 286 |
uterus | 100% | 5059.71 | 170 / 170 | 98% | 8.72 | 450 / 459 |
liver | 100% | 2368.57 | 226 / 226 | 98% | 9.94 | 396 / 406 |
ovary | 100% | 3156.74 | 180 / 180 | 97% | 6.13 | 419 / 430 |
skin | 100% | 2287.71 | 1808 / 1809 | 94% | 9.66 | 446 / 472 |
adrenal gland | 100% | 2094.25 | 258 / 258 | 94% | 5.46 | 216 / 230 |
adipose | 100% | 1831.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.07 | 29 / 29 |
spleen | 100% | 1998.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.59 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.59 | 1 / 1 |
blood vessel | 100% | 1621.78 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1448.62 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1222.33 | 833 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 1407.90 | 860 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 3.19 | 55 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0038061 | Biological process | non-canonical NF-kappaB signal transduction |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0042742 | Biological process | defense response to bacterium |
GO_0010008 | Cellular component | endosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0070530 | Molecular function | K63-linked polyubiquitin modification-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0043130 | Molecular function | ubiquitin binding |
GO_0060090 | Molecular function | molecular adaptor activity |
Gene name | TAB3 |
Protein name | TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 TAK1-binding protein 3, isoform CRA_c (TGF-beta activated kinase 1 (MAP3K7) binding protein 3) TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 3) (NF-kappa-B-activating protein 1) (TAK1-binding protein 3) (TAB-3) (TGF-beta-activated kinase 1-binding protein 3) |
Synonyms | MAP3K7IP3 hCG_1644389 |
Description | FUNCTION: Adapter required to activate the JNK and NF-kappa-B signaling pathways through the specific recognition of 'Lys-63'-linked polyubiquitin chains by its RanBP2-type zinc finger (NZF) . Acts as an adapter linking MAP3K7/TAK1 and TRAF6 to 'Lys-63'-linked polyubiquitin chains . The RanBP2-type zinc finger (NZF) specifically recognizes Lys-63'-linked polyubiquitin chains unanchored or anchored to the substrate proteins such as RIPK1/RIP1 and RIPK2: this acts as a scaffold to organize a large signaling complex to promote autophosphorylation of MAP3K7/TAK1, and subsequent activation of I-kappa-B-kinase (IKK) core complex by MAP3K7/TAK1 . .; FUNCTION: [Isoform 2]: May be an oncogenic factor. . |
Accessions | A0A0A0MQY2 ENST00000467136.5 ENST00000378930.7 [Q8N5C8-1] ENST00000378933.5 [Q8N5C8-1] F6SS63 ENST00000378932.6 [Q8N5C8-2] ENST00000288422 ENST00000288422.4 [Q8N5C8-1] Q8N5C8 |